Former Humanigen director arrested for insider trading

featured-image

wingedwolf A former director and chief scientific officer of bankrupt COVID-19 drug developer Humanigen ( OTC:HGENQ ) has been arrested in Switzerland on charges that he engaged in insider trading and 10b5-1 plan abuses. Dale Chappell is accused of avoiding more than $38M in.